Merus’ $460m Upsized Follow-On Offering of Common Shares

Latham & Watkins and NautaDutilh advised Merus on the offering.Merus N.V., an oncology company in the clinical stage, successfully raised an estimated USD 460 million in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Georgio Naffaa

This content is for Standard 1 Year members only.
Login Join Now